Affiliation:
1. Galgotias University Pharmacy Greater Noida India
2. Galgotias University Department of Pharmacy Greater Noida India
Abstract
Photosensitizers (PS) are effective in treating a wide range of tumours using the timetested
technique of photodynamic therapy (PDT). Light has been employed for centuries as a curative
modality due to its efficacy. Since the effects of using certain dyes in conjunction with light irradiation
were first proven around the turn of the 20th century, new PDT methods have been created. Current
research focuses mostly on methods to lessen or eliminate unwanted side effects and enhance the
drug's pharmacokinetic qualities. The FDA's decision to approve PDT as the first drug/device combo
is not surprising, given the widespread curiosity and volume of published material on the subject. In
PDT, light energy is combined with a PS to destroy tumour cells after its activation by light. In comparison
to chemotherapy and/or radiation treatment, PDT often has fewer adverse effects and is safer.
Several different PSs may be used to diagnose tumours, in addition to their therapeutic use. Photodynamic
diagnostics (PDD) is the term used to describe methods like these. In this review, we present a
high-level introduction to the diagnostic and therapeutic uses of PDT in cancer. The need of developing
predictors to determine the response to therapy will be explored in relation to the assessment of
PDT therapeutic effectiveness in the clinic. The use of PDT to treat different tumours will also be
shown through case studies. The potential of combining PDT with other forms of treatment, such as
chemotherapy, radiation, surgery, and immunotherapy, to increase efficacy against tumours will also
be highlighted. Results from PDT alone may not be as good as those from PDT combined with other
therapies. It's also possible that lower dosages used in combination therapy will have fewer adverse
effects and provide better outcomes than each individual treatment would. It is possible that the therapeutic
uses of PDT might be broadened by a greater knowledge of the efficacy of PDT in a combination
context in the clinic, as well as the optimisation of such complicated multimodal therapies.
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Oncology,Molecular Medicine